Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$58.6M |
| 2 |
B
Barrick Mining
B
|
+$42.7M |
| 3 |
Henry Schein
HSIC
|
+$41.4M |
| 4 |
Qualcomm
QCOM
|
+$28.7M |
| 5 |
Republic Services
RSG
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$64.4M |
| 2 |
General Dynamics
GD
|
+$35.5M |
| 3 |
THI
TIM HORTONS INC COM, CANADA
THI
|
+$31.8M |
| 4 |
Apple
AAPL
|
+$30.2M |
| 5 |
Johnson & Johnson
JNJ
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.42% |
| 2 | Technology | 13.9% |
| 3 | Industrials | 10.95% |
| 4 | Consumer Staples | 10.07% |
| 5 | Energy | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Globus Medical
GMED
$11.4B
| $1.27M | ﹤0.01% |
53,600
+2,800
| +6% | +$62K |
|
|
RP
1577
DELISTED
RealPage, Inc.
RP
| $1.27M | ﹤0.01% |
58,000
+900
| +2% | +$17.8K |
|
1578
AAR Corp
AIR
$5.86B
| $1.27M | ﹤0.01% |
45,800
+1,000
| +2% | +$25.9K |
|
|
HTWR
1579
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.27M | ﹤0.01% |
17,300
+400
| +2% | +$30.4K |
|
1580
Cal-Maine
CALM
$3.87B
| $1.27M | ﹤0.01% |
32,500
+700
| +2% | +$29.8K |
|
1581
Veeva Systems
VEEV
$38.4B
| $1.27M | ﹤0.01% |
48,000
+800
| +2% | +$22.5K |
|
1582
LCI Industries
LCII
$2.61B
| $1.27M | ﹤0.01% |
24,800
+400
| +2% | +$18.7K |
|
|
SNR
1583
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.27M | ﹤0.01% |
+77,016
| New | +$1.33M |
|
|
MDAS
1584
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $1.26M | ﹤0.01% |
64,000
| – | – |
|
1585
Scansource
SCSC
$1.05B
| $1.26M | ﹤0.01% |
31,400
| – | – |
|
|
SAFE
1586
Safehold
SAFE
$1.08B
| $1.26M | ﹤0.01% |
18,942
+493
| +3% | +$32.8K |
|
|
MACK
1587
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.26M | ﹤0.01% |
14,146
| – | – |
|
|
LCI
1588
DELISTED
Lannett Company, Inc.
LCI
| $1.26M | ﹤0.01% |
+7,325
| New | +$1.36M |
|
1589
OneSpan
OSPN
$601M
| $1.25M | ﹤0.01% |
44,400
| – | – |
|
|
PDLI
1590
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.25M | ﹤0.01% |
162,200
+3,900
| +2% | +$30.9K |
|
|
DO
1591
DELISTED
Diamond Offshore Drilling
DO
| $1.25M | ﹤0.01% |
34,069
-500
| -1% | -$17.9K |
|
1592
Cato Corp
CATO
$65.3M
| $1.25M | ﹤0.01% |
29,600
+500
| +2% | +$18.8K |
|
1593
Hope Bancorp
HOPE
$1.82B
| $1.25M | ﹤0.01% |
86,700
+1,700
| +2% | +$24K |
|
|
RESI
1594
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.25M | ﹤0.01% |
64,300
+1,500
| +2% | +$32K |
|
1595
Exponent
EXPO
$3.25B
| $1.25M | ﹤0.01% |
60,400
+1,200
| +2% | +$23.3K |
|
|
OSG
1596
Octave Specialty Group
OSG
$205M
| $1.25M | ﹤0.01% |
50,800
+2,900
| +6% | +$67.5K |
|
1597
Cleveland-Cliffs
CLF
$7.08B
| $1.25M | ﹤0.01% |
174,300
+17,100
| +11% | +$149K |
|
|
EGOV
1598
DELISTED
NIC Inc
EGOV
| $1.24M | ﹤0.01% |
69,100
+1,400
| +2% | +$25K |
|
|
HW
1599
DELISTED
Headwaters Inc
HW
| $1.24M | ﹤0.01% |
82,800
+1,700
| +2% | +$22.2K |
|
|
CMRX
1600
DELISTED
Chimerix, Inc.
CMRX
| $1.24M | ﹤0.01% |
30,800
+5,800
| +23% | +$196K |
|
Similar funds
Swiss National Bank's Q4 2014 Portfolio in Review
As of Q4 2014, Swiss National Bank held 2,649 positions worth $26.7B, up 2.3% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Swiss National Bank's Q4 2014 filing shows 120 new, 1,249 increased, 564 reduced and 81 closed positions. Its largest new stake was Stellantis: 7,902,518 shares worth $59.9M. The largest sale was KINDER MORGAN MANAGEMENT LLC, an estimated $64.4M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
- Swiss National Bank's largest Q4 2014 buy was Stellantis: 7,902,518 shares worth $59.9M.
- Swiss National Bank added most to Barrick Mining in Q4 2014, an estimated $42.7M increase.
- Swiss National Bank's biggest Q4 2014 reduction was Apple, cutting an estimated $30.2M.
- Swiss National Bank fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $64.4M.
- Swiss National Bank's ten largest holdings make up 13% of its $26.7B portfolio in Q4 2014.
- Swiss National Bank opened 120 new positions and closed 81 in Q4 2014.
- Swiss National Bank's portfolio value rose 2.3% quarter-over-quarter to $26.7B.
Based on Swiss National Bank's 13F filing for Q4 2014, filed 3 Feb 2015.